gptkbp:instanceOf
|
gptkb:biotechnology
|
gptkbp:CEO
|
gptkb:Gordon_Sanghera
|
gptkbp:collaboratesWith
|
gptkb:Wellcome_Trust
gptkb:Genomics_England
|
gptkbp:founded
|
2005
|
gptkbp:founder
|
gptkb:Hagan_Bayley
|
gptkbp:fullName
|
gptkb:Oxford_Nanopore_Technologies
|
gptkbp:headquartersLocation
|
gptkb:Oxford,_United_Kingdom
|
https://www.w3.org/2000/01/rdf-schema#label
|
Oxford Nanopore
|
gptkbp:industry
|
gptkb:biotechnology
|
gptkbp:listedOn
|
gptkb:FTSE_250_Index
|
gptkbp:market
|
agriculture
life sciences
environmental monitoring
clinical diagnostics
|
gptkbp:notableAchievement
|
developed portable DNA sequencers
|
gptkbp:numberOfEmployees
|
over 900 (2023)
|
gptkbp:patent
|
nanopore-based sequencing technology
|
gptkbp:product
|
gptkb:Flongle
gptkb:GridION
gptkb:MinION
gptkb:PromethION
|
gptkbp:researchInterest
|
genomics
DNA sequencing
RNA sequencing
|
gptkbp:servesArea
|
worldwide
|
gptkbp:stockExchange
|
gptkb:London_Stock_Exchange
|
gptkbp:stockSymbol
|
ONT
|
gptkbp:technology
|
nanopore sequencing
|
gptkbp:website
|
https://nanoporetech.com
|
gptkbp:bfsParent
|
gptkb:FASTQ
gptkb:RNA-seq
gptkb:Telomere-to-Telomere_Consortium
|
gptkbp:bfsLayer
|
7
|